Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Papathanasiou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Diabetes, Obesity & Metabolism|February 4, 2020
Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approachTheodoros Papathanasiou, Anders Strathe, Henrik Agersø, et al.
The AAPS Journal|July 31, 2019
Optimizing Dose-Finding Studies for Drug Combinations Based on Exposure-Response ModelsTheodoros Papathanasiou, Anders Strathe, Rune Viig Overgaard, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 28, 2015
Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative painTheodoros Papathanasiou, Rasmus Vestergaard Juul, Anne-Marie Heegaard, et al.
Pharmaceutical Research|July 6, 2016
Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the RatTheodoros Papathanasiou, Rasmus Vestergaard Juul, Charlotte Gabel-Jensen, et al.
The AAPS Journal|April 25, 2018
Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug CombinationsTheodoros Papathanasiou, Anders Strathe, Andrew C Hooker, et al.
Clinical Pharmacokinetics|April 17, 2021
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin<sup>®</sup> in Children and AdultsTheodoros Papathanasiou, Henrik Agersø, Birgitte Bentz Damholt, et al.
The AAPS Journal|August 31, 2017
Quantification of the Pharmacodynamic Interaction of Morphine and Gabapentin Using a Response Surface ApproachTheodoros Papathanasiou, Rasmus Vestergaard Juul, Charlotte Gabel-Jensen, et al.
Bioanalysis|January 22, 2019
Simultaneous quantification of high-dose naloxone and naloxone-3-β-d-glucuronide in human plasma by UHPLC-MS/MSKenneth T Kongstad, Theodoros Papathanasiou, Anders D Springborg, et al.
Targeted Oncology|September 16, 2025
Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 StudyPatrick Hanafin, Yu Liu Ho, Theodoros Papathanasiou, et al.
British Journal of Cancer|April 13, 2026
Exposure-response analyses for belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma from DREAMM-6 Arm B and DREAMM-7Theodoros Papathanasiou, Xi Chen, Fernando Carreno, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Diabetes, Obesity & Metabolism|February 4, 2020
Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approachTheodoros Papathanasiou, Anders Strathe, Henrik Agersø, et al.
The AAPS Journal|July 31, 2019
Optimizing Dose-Finding Studies for Drug Combinations Based on Exposure-Response ModelsTheodoros Papathanasiou, Anders Strathe, Rune Viig Overgaard, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 28, 2015
Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative painTheodoros Papathanasiou, Rasmus Vestergaard Juul, Anne-Marie Heegaard, et al.
Pharmaceutical Research|July 6, 2016
Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the RatTheodoros Papathanasiou, Rasmus Vestergaard Juul, Charlotte Gabel-Jensen, et al.
The AAPS Journal|April 25, 2018
Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug CombinationsTheodoros Papathanasiou, Anders Strathe, Andrew C Hooker, et al.
Clinical Pharmacokinetics|April 17, 2021
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin<sup>®</sup> in Children and AdultsTheodoros Papathanasiou, Henrik Agersø, Birgitte Bentz Damholt, et al.
The AAPS Journal|August 31, 2017
Quantification of the Pharmacodynamic Interaction of Morphine and Gabapentin Using a Response Surface ApproachTheodoros Papathanasiou, Rasmus Vestergaard Juul, Charlotte Gabel-Jensen, et al.
Bioanalysis|January 22, 2019
Simultaneous quantification of high-dose naloxone and naloxone-3-β-d-glucuronide in human plasma by UHPLC-MS/MSKenneth T Kongstad, Theodoros Papathanasiou, Anders D Springborg, et al.
Targeted Oncology|September 16, 2025
Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 StudyPatrick Hanafin, Yu Liu Ho, Theodoros Papathanasiou, et al.
British Journal of Cancer|April 13, 2026
Exposure-response analyses for belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma from DREAMM-6 Arm B and DREAMM-7Theodoros Papathanasiou, Xi Chen, Fernando Carreno, et al.
Pageof 2